iSpecimen Inc.iSpecimen Inc.iSpecimen Inc.

iSpecimen Inc.

No trades
See on Supercharts
Market capitalization
‪2.68 M‬USD
−1.2275USD
‪−11.10 M‬USD
‪9.93 M‬USD
‪5.34 M‬
Beta (1Y)
−2.10

About iSpecimen Inc.

CEO
Tracy Wilson Curley
Headquarters
Lexington
Employees (FY)
53
Founded
2009
FIGI
BBG00734QDL2
iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Lexington, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ISPC is 0.2778 USD — it has decreased by 5.86% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange iSpecimen Inc. stocks are traded under the ticker ISPC.
iSpecimen Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
ISPC stock is 10.99% volatile and has beta coefficient of −2.10. Check out the list of the most volatile stocks — is iSpecimen Inc. there?
ISPC earnings for the last quarter are −0.23 USD per share, whereas the estimation was −0.35 USD resulting in a 34.29% surprise. The estimated earnings for the next quarter are −0.24 USD per share. See more details about iSpecimen Inc. earnings.
iSpecimen Inc. revenue for the last quarter amounts to ‪2.78 M‬ USD despite the estimated figure of ‪2.24 M‬ USD. In the next quarter revenue is expected to reach ‪3.04 M‬ USD.
Yes, you can track iSpecimen Inc. financials in yearly and quarterly reports right on TradingView.
ISPC stock has risen by 30.67% compared to the previous week, the month change is a 23.96% rise, over the last year iSpecimen Inc. has showed a 83.47% decrease.
ISPC net income for the last quarter is ‪−3.07 M‬ USD, while the quarter before that showed ‪−2.11 M‬ USD of net income which accounts for −45.56% change. Track more iSpecimen Inc. financial stats to get the full picture.
Today iSpecimen Inc. has the market capitalization of ‪2.68 M‬, it has increased by 60.30% over the last week.
No, ISPC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ISPC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade iSpecimen Inc. stock right from TradingView charts — choose your broker and connect to your account.
ISPC reached its all-time high on Nov 29, 2021 with the price of 28.9799 USD, and its all-time low was 0.2001 USD and was reached on Apr 5, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 53.00 employees. See our rating of the largest employees — is iSpecimen Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So iSpecimen Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating iSpecimen Inc. stock shows the sell signal. See more of iSpecimen Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on iSpecimen Inc. future price: according to them, ISPC price has a max estimate of 3.00 USD and a min estimate of 3.00 USD. Read a more detailed iSpecimen Inc. forecast: see what analysts think of iSpecimen Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. iSpecimen Inc. EBITDA is ‪−9.10 M‬ USD, and current EBITDA margin is −91.70%. See more stats in iSpecimen Inc. financial statements.